- Moneycontrol /
- Market /
- Pharmaceuticals /
- NINE MONTHLY RESULTS
BSE Live
Feb 19, 16:00Prev. Close
316.00
Open Price
331.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Nine Months Results of Mercury Laboratories (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 45.50 | 43.45 | 39.03 | 35.03 | 37.72 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 45.50 | 43.45 | 39.03 | 35.03 | 37.72 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 17.34 | 17.61 | 19.07 | 12.20 | 14.56 | |
| Purchase of Traded Goods | 1.26 | 0.96 | -- | 1.19 | 2.51 | |
| Increase/Decrease in Stocks | 1.20 | 2.23 | -0.84 | 1.67 | -0.11 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 6.82 | 5.73 | 5.39 | 5.23 | 5.33 | |
| Depreciation | 1.37 | 1.21 | 1.01 | 0.78 | 0.82 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 12.37 | 11.96 | 11.96 | 9.77 | 9.49 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.14 | 3.76 | 2.44 | 4.18 | 5.12 | |
| Other Income | 0.48 | 0.66 | 0.30 | 0.42 | 0.28 | |
| P/L Before Int., Excpt. Items & Tax | 5.62 | 4.42 | 2.75 | 4.60 | 5.41 | |
| Interest | 0.63 | 0.79 | 0.68 | 0.69 | 0.87 | |
| P/L Before Exceptional Items & Tax | 4.99 | 3.63 | 2.06 | 3.91 | 4.54 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 4.99 | 3.63 | 2.06 | 3.91 | 4.54 | |
| Tax | 1.41 | 1.02 | 0.43 | 1.77 | 1.19 | |
| P/L After Tax from Ordinary Activities | 3.58 | 2.62 | 1.63 | 2.14 | 3.35 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 3.58 | 2.62 | 1.63 | 2.14 | 3.35 | |
| Equity Share Capital | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 29.85 | 21.80 | 13.57 | 17.82 | 27.09 | |
| Diluted EPS | 29.85 | 21.80 | 13.57 | 17.82 | 27.09 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 29.85 | 21.80 | 13.57 | 17.82 | 27.09 | |
| Diluted EPS. | 29.85 | 21.80 | 13.57 | 17.82 | 27.09 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
30.07.2019
Mercury Labs Standalone June 2019 Net Sales at Rs 14.75 crore, up 13.17% Y-o-Y
30.05.2019
Mercury Labs Standalone March 2019 Net Sales at Rs 12.07 crore, down 5.95% Y-o-Y
30.01.2019
Mercury Labs Standalone December 2018 Net Sales at Rs 17.53 crore, up 26.56% Y-o-Y
02.11.2018
Mercury Labs Standalone September 2018 Net Sales at Rs 12.88 crore, down 11.33% Q-o-Q
30.07.2019
Mercury Labs Standalone June 2019 Net Sales at Rs 14.75 crore, up 13.17% Y-o-Y
30.05.2019
Mercury Labs Standalone March 2019 Net Sales at Rs 12.07 crore, down 5.95% Y-o-Y
30.01.2019
Mercury Labs Standalone December 2018 Net Sales at Rs 17.53 crore, up 26.56% Y-o-Y
02.11.2018
Mercury Labs Standalone September 2018 Net Sales at Rs 12.88 crore, down 11.33% Q-o-Q
